← Back to Blog
Clinical Trials and Patient Centricity: The New Era of Medical Research

Clinical Trials and Patient Centricity: The New Era of Medical Research

By Corterve Editorial Team

Last updated

Editorial policy

Discover how shifting the focus toward patient centricity is transforming clinical trial design, accelerating recruitment, and improving retention rates.

Clinical Trials and Patient Centricity: The New Era of Medical Research

For decades, the design of clinical trials prioritized clinical endpoints, regulatory requirements, and investigator convenience. However, a paradigm shift is underway. Today, the global clinical research estate is moving rapidly toward patient centricity—an approach that designs clinical trials around the lived experiences, needs, and preferences of patients.

By putting patients first, research organizations are not only practicing ethical medicine but are also solving some of the greatest operational bottlenecks in clinical development.


What is Patient Centricity in Clinical Trials?

Patient centricity means engaging patients as active partners rather than passive subjects. It involves designing studies that:

  • Minimize the burden of participation (e.g., fewer site visits, decentralized trial components).
  • Incorporate patient-reported outcomes (PROs) alongside traditional clinical measurements.
  • Ensure clear, jargon-free communication from recruitment through to trial completion.

When trials are designed with the patient's daily routine in mind, the friction of participating drops significantly.


Why the Shift to Patient Centricity is Urgent

The traditional clinical trial model is facing severe efficiency challenges:

  1. Low Enrollment: Under-enrollment is the leading cause of clinical trial delays, with up to 80% of trials failing to meet their initial recruitment timelines.
  2. High Attrition Rates: Even when patients enroll, keeping them engaged is difficult. The average dropout rate across clinical trials is roughly 20%.
  3. Lack of Diversity: Historical recruitment methods systematically exclude underrepresented demographics, resulting in clinical data that lacks real-world generalizability.

By focusing on patient comfort, financial transparency, and ongoing education, trial sponsors can dramatically improve recruitment and retention rates.


Strategies for Designing Patient-Centric Trials

To transition successfully to a patient-first model, sponsors and Contract Research Organizations (CROs) should implement three core strategies:

1. Leverage Decentralized Trial Tools (DCTs)

Decentralization uses digital health technologies (DHTs), telemedicine, and local nursing networks to bring the trial directly to the patient's home.

  • Wearable Sensors: Continuous monitoring of vital signs reduces the need for frequent clinic visits.
  • E-Consent: Interactive video and digital signatures allow patients to learn about trials at their own pace with family members present.

2. Simplify the Protocol

Complex protocols with burdensome schedules of assessments are a major driver of patient dropout. During the protocol design phase, sponsors should ask: Is this specific lab test or in-person visit absolutely necessary for our primary endpoints? If the answer is no, consider removing it or outsourcing it to a local clinic.

3. Communicate Results Back to Participants

Historically, once a trial concluded, patients never heard from investigators again. Post-trial engagement—such as sharing plain-language summaries of the trial's results—builds lasting trust within the community and encourages future participation.


The Path Forward with Corterve

At Corterve, we believe that bridging the gap between cutting-edge clinical research and everyday patients is the key to medical breakthroughs. By optimizing the patient journey through seamless matching technology and empathetic engagement, we help build an inclusive, efficient future for clinical trials.

Are you looking to optimize your patient recruitment or find a clinical trial near you? Explore our patient matching solutions today.